RxDoctor Payments Data

Maria Christina Lyons, PA

Physician Assistant · Omaha, NENPI 1851627285

Payments from drug & device makers

$1,514in general payments, 2019–2025

Across 81 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$528
  • AbbVie$263
  • Myovant Sciences Inc.$132
  • Dendreon Pharmaceuticals LLC$66
  • Johnson & Johnson$63
  • Intuitive Surgical$55
  • plus $408 from 14 others

What the payments were for

  • Food & beverage$1,15977%
  • Education$35523%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,514 in reported general payments places this provider in the 75th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Medicare billing

Part B allowed, 2024
$176,769
Medicare patients
454
Services billed
11,790

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron83$44,597
MyrbetriqMirabegron39$26,639
Potassium Citrate ErPotassium Citrate37$3,244
Tamsulosin Hcl209$2,667
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst42$2,156
Silodosin30$1,842
Dutasteride49$1,207
Solifenacin Succinate66$1,146
Finasteride123$1,076
Oxybutynin Chloride ErOxybutynin Chloride16$674
Oxybutynin Chloride40$437
Allopurinol32$419
Alfuzosin Hcl ErAlfuzosin Hcl26$418
Testosterone Cypionate15$394
Ciprofloxacin Hcl60$331

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$46$44,59783 claims
Astellas Pharma US IncMyrbetriq$528$26,63939 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →